EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats

Takashi Asano iD, Meiyan Xuan, Naohiro Iwata, Jun Takayama, Kousuke Hayashi iD, Yosuke Kato, Toshiya Aoyama, Hiroshi Sugo, Hirokazu Matsuzaki, Bo Yuan iD, Shinya Kamiuchi, Yasuhide Hibino und 2 weitere

International Journal of Molecular Sciences · 02.06.2023 · 24 (11) · 9663

DOI: 10.3390/ijms24119663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.06.2023. Verfasst von Takashi Asano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan. Hauptthemen laut MEDLINE: Brain Ischemia, Neuroprotective Agents, Reperfusion Injury. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue plasminogen activator, aiming to restore cerebral blood flow (CBF), has been used for acute ischemic strokes in clinics; however, its narrow therapeutic time window remains a serious concern. To develop novel prophylactic drugs to alleviate cerebral ischemia/reperfusion injuries, ferulic acid derivative 012 (FAD012) was synthesized and showed comparable antioxidant properties to ferulic acid (FA) and probably possesses the potent ability to cross the blood–brain barrier. A more potent cytoprotective effect of FAD012 against H2O2-induced cytotoxicity in PC12 cells was also observed. In vivo toxicity was not observed in rats given a long-term oral administration of FAD012, indicating its good tolerability. A one-week-course oral administration of FAD012 significantly alleviated middle cerebral artery occlusion (MCAO)-induced cerebral ischemia/reperfusion injuries in rats, accompanied by the restoration of CBF and endothelial nitrogen oxide synthetase (eNOS) expression. Treatment with FAD012 significantly restored the cell viability and eNOS expression damaged by H2O2, used to mimic MCAO-triggered oxidative stress, in rat brain microvascular endothelial cells. Our findings suggested that FAD012 protected the viability of vascular endothelium and maintained eNOS expression, ultimately contributing to the restoration of CBF, and may provide a rationale for the development of FAD012 into an effective prophylactic drug for patients at high risk of stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain IschemiaNeuroprotective AgentsReperfusion InjuryAnimalsRatsCerebrovascular CirculationEndothelial CellsHydrogen PeroxideInfarction, Middle Cerebral ArteryNitric Oxide SynthaseRats, Sprague-DawleyTissue Plasminogen ActivatorCoumaric Acids

Stichwörter der Autor:innen

cerebral blood flowendothelial nitrogen oxide synthetaseferulic acid derivativeischemia/reperfusion injurymiddle cerebral artery occlusionoxidative stress

Substanzen

Hydrogen PeroxideNeuroprotective AgentsNitric Oxide SynthaseTissue Plasminogen Activatorferulic acidCoumaric AcidsFAD012

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Laboratory of Organic and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Laboratory of Immunobiochemistry, Faculty of Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.

ORCID-Profile: Takashi Asano, Kousuke Hayashi, Bo Yuan

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Asano, T., Xuan, M., Iwata, N., Takayama, J., Hayashi, K., Kato, Y., Aoyama, T., Sugo, H., Matsuzaki, H., Yuan, B., Kamiuchi, S., Hibino, Y., Sakamoto, T., & Okazaki, M. (2023). Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats. International Journal of Molecular Sciences, 24(11), 9663. https://doi.org/10.3390/ijms24119663

Vancouver

Asano T, Xuan M, Iwata N, Takayama J, Hayashi K, Kato Y, et al. Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats. International Journal of Molecular Sciences. 2023;24(11):9663. doi:10.3390/ijms24119663

BibTeX
@article{Asano2023,
  author = {Asano, Takashi and Xuan, Meiyan and Iwata, Naohiro and Takayama, Jun and Hayashi, Kousuke and Kato, Yosuke and Aoyama, Toshiya and Sugo, Hiroshi and Matsuzaki, Hirokazu and Yuan, Bo and Kamiuchi, Shinya and Hibino, Yasuhide and Sakamoto, Takeshi and Okazaki, Mari},
  title = {Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {9663},
  doi = {10.3390/ijms24119663}
}
Kostenlos starten →